Speaker Index

2001-present

Speaker Date Title
Adkins, Doug 4/18/03 Melanocortin-4 receptor mutations in obesity (PowerPoint/HTML)
  9/12/03 Use of myeloid CSF's during therapy of AML (PowerPoint/HTML)
  9/10/04 Therapy for squamous cell carcinoma of the head and neck (PowerPoint/HTML)
Andritsos, Leslie 1/9/01 Leukemia cutis
  1/18/02 Post-transfusion purpura
  3/22/02 Acquired von Willebrand disease
  5/3/02 Hairy cell leukemia
  6/7/02 Iron deficiency secondary to celiac disease
  10/18/02 Thymoma (PowerPoint)
  3/28/03 Methylene tetrahydrofolate reductase and thrombosis (PowerPoint)
  1/16/04 Castleman's disease (PowerPoint)
  1/14/05 Stem cell mobilization: current therapies and future directions
  5/27/05 Clinical trials of AMD3100 for stem cell mobilization (PowerPoint)
Anim, Odame (Samuel) 10/30/09 A case of failure to thrive and pancytopenia in a toddler (PowerPoint)
Ansstas, George 9/26/08 Update on advanced liver cancer treatments (PowerPoint)
  1/16/09 Multiple myeloma: review and update (PowerPoint)
  4/10/09 Treatment options for castrate-resistant prostate cancer (PowerPoint)
  6/19/09 Update on GIST (PowerPoint)
  10/2/09 Refractory CLL: treatment approaches (PowerPoint)
  10/23/09 Hairy cell leukemia (PowerPoint)
Azok, Jill 1/23/09 Antiphospholipid antibody syndrome in children (PowerPoint)
Bartlett, Nancy 3/21/03 Treatment of early stage favorable Hodgkin's disease
  9/16/05 Current therapies for advanced stage mycosis fungoides (PowerPoint)
Baggstrom, Maria 3/21/08 Adjuvant chemotherapy in early stage lung cancer (PDF)
Bednarski, Jeff 11/3/06 CNS germinomas, diabetes insipidus, and chemotherapy: challenges in management (PowerPoint)
  2/2/07 Thymic carcinoma: should biology dictate therapy? (PowerPoint)
Beer, David 12/2/05 Gene and protein-based strategies for lung cancer diagnosis and prognosis
Bernal-Mizrachi, Leon 10/4/02 Markers of endothelial injury in GVHD and TTP (PowerPoint)
  1/10/03 Cytokines, angiogenesis, and tumor growth (PowerPoint)
  2/14/03 Circulating endothelial precursors and tumor angiogenesis (PowerPoint)
  6/27/03 Autoimmunity and myelodysplastic syndrome (PowerPoint)
  10/31/03 A multigenic program mediating breast cancer metastasis to bone (PowerPoint)
  3/12/04 Tax-induced tumors
  5/6/05 The role of NF-kB in lymphomagenesis
Bessler, Monica 5/31/02 Dyskeratosis congenita
  11/21/03 Dyskeratosis congenita: RNA processing versus telomere maintenance
  1/14/05 Dysfunctional telomere maintenance in the pathogenesis of myelodysplastic syndromes (PowerPoint)
  3/24/06 Telomere length in aplastic anemia and myelodysplastic syndromes (PowerPoint/HTML)
  7/14/06 Bone marrow failure (PowerPoint/HTML)
  3/16/07 Complement inhibition for the treatment of paroxysmal nocturnal hemoglobinuria: results from the TRIUMPH/SEPHARD study (PowerPoint)
Blinder, Morey 2/8/02 Refractory ITP
  3/8/02 Glucose 6-phosphate dehydrogenase deficiency
  5/21/04 Iron overload and treatment with a new iron chelator (PowerPoint)
  4/29/05 Azathioprine and acquired aplastic anemia (PowerPoint)
  11/11/05 Sickle cell trait and sudden death (PowerPoint)
  7/7/06 Peripheral blood smears (PowerPoint)
  7/21/06 Anemia (PowerPoint)
  8/4/06 Bleeding disorders (PowerPoint)
  9/1/06 Diagnostic hematology: monoclonal gammopathies and hemoglobin disorders (PowerPoint)
  11/3/06 Unexplained iron deficiency anemia (PowerPoint)
  7/11/08 Overview of anemia (PowerPoint)
  7/18/08 Peripheral blood morphology (PowerPoint)
  7/25/08 Disorders of hemoglobin and gammopathies (PowerPoint)
  8/1/08 Bleeding, blood products and transfusion therapy (PowerPoint)
  8/22/08 Sickle cell anemia (PowerPoint)
  7/10/09 Overview of anemia (I) (PowerPoint)
  7/17/09 Overview of anemia (II) (PowerPoint)
  7/24/09 Disorders of hemoglobin and gammopathies (PowerPoint)
  7/31/09 Bleeding, blood products and transfusion therapy (PowerPoint)
  8/28/09 Sickle cell disease (PowerPoint)
  1/15/10 The study of hemoglobinopathies at Washington University (PowerPoint)
Blum, Bill 10/19/01 Cytogenetic risk factors in AML
  1/4/02 CML overview
  2/8/02 HLA typing
  9/13/02 Low-dose TBI plus cyclophosphamide as a conditioning regimen for donor transplantation (PowerPoint)
  1/24/03 FLT3: a target for molecular therapy in AML (PowerPoint)
Blum, Kristie 1/2/01 Anaplastic large cell lymphoma
  9/28/01 Apoptosis review
  4/26/02 MALT lymphoma
  9/20/02 T-cell prolymphocytic leukemia (PowerPoint)
  1/31/03 Proteasome inhibition in Hodgkin's lymphoma (PowerPoint)
Bose, Ron 3/21/08 Understanding oncogenic tyrosine kinases and their inhibitors using phosphoproteomics (PowerPoint)
Brenner, Warren 10/17/03 Primary amyloidosis: an overview (PowerPoint)
  2/13/04 Management of refractory ITP (PowerPoint)
  5/28/04 Adjuvant therapy for non-small cell lung cancer (PowerPoint)
  11/12/04 Philadelphia chromosome positive ALL (PowerPoint)
  3/18/05 Hereditary non-polyposis colon cancer (PowerPoint)
  2/17/06 Management of HER2/neu positive breast cancer in the adjuvant setting (PowerPoint)
  5/12/06 Splenic marginal zone lymphoma (PowerPoint)
Broze, George 1/18/02 Heparin resistance; unexplained elevation of the PTT in a patient on warfarin
  4/16/04 A patient with thrombocytopenia and congenital heart disease
  1/28/05 Occult malignancy in patients with idiopathic venous thromboembolism
  9/30/05 Hemophiliac admitted for cardiac cath and PCA (PowerPoint)
  3/14/08 Young woman with a bleeding history (PowerPoint)
Carson, Ken 10/5/07 Post-marketing pharmacovigilance and drug evaluation: is your RADAR on?
Cashen, Amanda 9/5/03 Chemoprevention of prostate cancer (PowerPoint)
  5/7/04 Anaplastic large cell lymphoma (PowerPoint)
  10/15/04 True histiocytic lymphoma (PowerPoint)
  3/11/05 Decitabine for the treatment of AML (PowerPoint)
  1/6/06 Autologous stem cell transplantation as initial treatment of diffuse large B-cell lymphoma (PowerPoint)
  5/26/06 Treatment-related AML associated with balanced chromosome translocations (PowerPoint)
  10/12/07 Autologous transplantation for the treatment of follicular lymphoma (PowerPoint)
Cassidy, James 10/26/01 Polymer-linked anthracyclines
Chang, Shao-Chun 9/7/01 MGUS and polyneuropathy
  5/10/02 Cryoglobulinemia
  11/8/02 Castleman's disease (PowerPoint)
Chawla, Jane 11/14/08 The natural killer cell neoplasms: can we overcome treatment-resistance? (PowerPoint)
  1/30/09 Pharmacogenetics and chemotherapy (PowerPoint)
  2/27/09 Acute intermittent porphyria (PowerPoint)
  5/15/09 Neoadjuvant chemotherapy for rectal cancer (PowerPoint)
  9/11/09 A phase II study of gemcitabine and pazopanib in metastatic pancreatic cancer
  11/6/09 In pursuit of personalized therapy for breast cancer: gene expression signatures (PowerPoint)
Cherian, Mathew 9/25/09 PARP (polyADP-ribose polymerase) and PARP inhibitors (PowerPoint)
  11/6/09 Genome sculpting mechanisms in cancer (PowerPoint)
Chia, Yee 10/31/08 Role of imaging in oncology (PowerPoint)
  1/30/09 The role of PET imaging in Hodgkin's disease (PowerPoint)
  3/20/09 Neoadjuvant therapy in potentially resectable pancreatic cancer (PowerPoint)
  6/19/09 Neoadjuvant endocrine therapy for hormone receptor-positive breast cancer (PowerPoint)
  9/18/09 Hedgehog signaling and breast cancer
  10/16/09 Dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) (PowerPoint)
Coplin, Maggi 9/21/01 Fludarabine-resistant CLL
  10/19/01 Large granular lymphocytic leukemia
  2/1/02 Hereditary elliptocytosis (alpha-spectrin defects)
  9/13/02 Iressa (EGFR antagonist) for non small cell lung cancer (PowerPoint)
  11/15/02 Staging of locally advanced breast cancer (PowerPoint)
  4/11/03 Desmoplastic small round cell tumor (PowerPoint)
  6/20/03 Treatment of post-thrombocythemic myelofibrosis with myeloid metaplasia (PowerPoint)
  1/23/04 20 year old girl with ankle pain (adamantinoma-like Ewing's sarcoma) (PowerPoint)
  4/16/04 Nonseminomatous germ cell tumors: brain metastasis at presentation (PowerPoint)
Crosby, Seth 2/15/08 Genetic analysis in the 21st century: the state of the art at the Genome Sequencing Center (PowerPoint)
Cullen, Kevin 1/25/02 Molecular determinants of treatment outcome in head and neck cancer
Dannenberg, Andrew 9/27/02 COX-2: A rational target for anti-cancer therapy
Dean, Jennifer 9/24/04 Neonatal stroke (PowerPoint)
  4/22/05 Bone marrow failure in dyskeratosis congenita (PowerPoint)
Denes, Alex 6/27/03 Aromatase inhibitors in breast cancer (PowerPoint)
  1/29/10 Medical oncology at Washington University - a brief history (PowerPoint)
Devine, Steve 1/17/03 Stem cell transplantation for PNH (PowerPoint)
  10/3/03 Allogeneic stem cell transplantation for non-Hodgkins lymphoma (PowerPoint)
DiPersio, John 1/24/03 Lymphangiogenesis (PowerPoint)
  10/24/03 Bone and marrow...are they related? (PowerPoint)
  9/3/04 Chronic myelogenous leukemia (PowerPoint)
  11/18/05 AMD3100 for stem cell mobilization: preclinical and clinical trials (PowerPoint)
  12/1/06 Review of Washington University mobilization database (PowerPoint)
  1/22/10 History of the Division of Oncology (PowerPoint)
Dmitrovsky, Ethan 7/27/07 Bidirectional translational research as a tool for discovery
Druley, Todd 11/4/05 Chromosome 21 and lymphoproliferation (PowerPoint)
  2/24/06 Hypermutability as a mechanism of carcinogenesis (PowerPoint)
Eby, Chuck 6/18/04 A mistaken diagnosis of familial ITP (May-Hegglin anomaly) (PowerPoint)
  5/6/05 Warfarin resistance
  5/19/06 Homozygous protein C deficiency (PowerPoint)
  8/18/06 Laboratory testing for venous thromboembolism risk assessment (PowerPoint)
  5/18/07 Thrombotic complications during treatment of bleeding in hemophiliacs (PowerPoint)
  5/16/08 Hemoglobin-based oxygen carrying substitutes: another setback (PowerPoint)
  8/29/08 Laboratory testing for venous thromboembolism risk assessment (PowerPoint)
  4/24/09 ABO incompatible red cell transfusions: incidence, consequences, management, and prevention (PowerPoint)
  8/7/09 Hemostasis and thrombophilia testing (PowerPoint)
Ellis, Matthew 3/25/05 Breast cancer classification by RNA profiling
Fehniger, Todd 9/10/04 GIST and imatinib (PowerPoint)
  1/21/05 Acquired hemophagocytic lymphohistiocytosis
  6/10/05 Lenalidomide therapy for MDS (PowerPoint)
  11/11/05 MicroRNA: a new key to unravel CLL pathogenesis and prognosis? (PowerPoint)
  3/10/06 NK cell receptors, their ligands, and allogeneic stem cell transplantation for myeloid malignancies (PowerPoint)
  12/1/06 Regulatory T cells in anti-tumor immunity (PowerPoint)
  3/23/07 Emerging therapies for fludarabine-refractory CLL (PowerPoint)
  4/18/08 Lenalidomide therapy for lymphoma (PowerPoint)
  3/13/09 Lenalidomide therapy for untreated acute myeloid leukemia in older (>60 years) adults (PowerPoint)
Fenske, Tim 1/3/03 CD30 as a target for therapy of Hodgkin's disease (PowerPoint)
  3/7/03 Post-transplant lymphoproliferative disorders: EBV not always to blame (PowerPoint)
  4/18/03 Renal cell carcinoma (PowerPoint)
  6/13/03 Rituxan for treatment of idiopathic factor VIII inhibitors (PowerPoint)
  10/24/03 c-Kit mutations in core binding factor leukemias
  3/5/04 C/EBP alpha mutations in the pathogenesis and prognosis of AML (PowerPoint)
  6/25/04 Chronic myelomonocytic leukemia (CMML) (PowerPoint)
  11/19/04 Hematologic and dermatologic abnormalities following targeted expression of AML1/ETO in mice
  4/15/05 Gene expression profiling in large cell lymphoma: emerging clinical applications (PowerPoint)
Field, Joshua 10/8/04 5-Azacytidine: the "new" treatment for MDS (PowerPoint)
  3/4/05 Sickle cell disease and stroke (PowerPoint)
  6/24/05 Platelet refractoriness/alloimmunization (PowerPoint)
  1/13/06 Cold agglutinin syndrome following allergenic transplant (PowerPoint)
  3/6/09 Asthma as a modifier of sickle cell disease severity (PowerPoint)
  1/15/10 Sickle cell studies at Washington University (PowerPoint)
Fong, Tom 9/16/05 Renal disorders in multiple myeloma (PowerPoint)
  2/17/06 Primary CNS lymphoma (PowerPoint)
  1/19/07 Copper deficiency and myelodysplasia (PowerPoint)
  5/4/07 Tumors of the small bowel (PowerPoint)
  1/4/08 EGFR inhibitors in advanced NSCLC (PowerPoint)
Fracasso, Paula 5/16/03 The cell cycle as a target for cancer therapy: early drug development of UCN-01
  4/21/06 Targeting the EGF receptor in cervical cancer (PowerPoint)
  5/25/07 Concurrent cetuximab, cisplatin, and radiation therapy in advanced cervical cancer (PowerPoint)
Frei-Jones, Melissa 10/21/05 Pediatric manifestations of FAP - hepatoblastoma and the role of APC (PowerPoint)
  2/3/06 Pheochromocytoma in a young child: long term follow-up and risk of second malignancy (PowerPoint)
Friedman, Henry 12/12/03 Management of glioma
Gauvain, Karen 1/9/01 Secondary acute promyelocytic leukemia
  1/4/02 Hemophagocytic lymphohistiocytosis (perforin mutation in familial form)
Ghobadi, Armin 11/13/09 FLT3 mutations and FLT3 targeted therapy in AML (PowerPoint)
  2/5/10 JAK2 inhibitors (PowerPoint)
Goodgame, Bo 9/2/05 Brain metastases in non-small cell lung cancer (PowerPoint)
  1/27/06 GIST: a review and update (PowerPoint)
  4/14/06 Virus, lymphoma, and worms: complications and treatment of HTLV1 (PowerPoint)
  11/17/06 Tailored toxic therapy: identifying platinum resistance (PowerPoint)
  3/9/07 Prognostic value of FDG-PET for early stage carcinomas (PowerPoint)
  5/16/08 To bleed or not to bleed: adverse effects of anti-angiogenics (PowerPoint)
  4/10/09 Old dogmas, new tricks: the changing treatment of advanced non-small cell lung cancer (PowerPoint)
Gopalan, Priya 12/16/05 Targeted therapies for advanced non-small cell lung cancer (PowerPoint)
  4/7/06 Fanconi anemia (PowerPoint)
  10/27/06 Neoadjuvant endocrine therapy in breast cancer (PowerPoint)
  3/16/07 Ovarian cancer (PowerPoint)
  2/29/08 Tumor angiogenesis (PowerPoint)
  10/10/08 Bone metastases in solid tumors (PowerPoint)
  2/6/09 Bone marrow micrometastases (PowerPoint)
Govindan, Ramaswamy 5/2/03 Anti-emetics (PowerPoint)
  11/19/04 Adjuvant therapy for NSCLC: current data and emerging issues
  1/25/08 Cancer metastases: a twist in the tale, the story of epithelial mesenchymal transitions
Goyal, Sagun 9/25/09 Hyperhemolytic syndrome in SCD (PowerPoint)
  11/20/09 Bortezomib in the treatment of AL amyloidosis (PowerPoint)
  2/5/10 Etanercept in the management for acute graft-versus-host disease (PowerPoint)
Graubert, Tim 4/12/02 Molecular biology of acute myelogenous leukemia
  3/25/05 Genetics of susceptibility to alkylator-induced cancer (PowerPoint)
Grossman, Bill 10/12/01 Loxoscelism (brown recluse spider bite)
  2/1/02 Autoimmune neutropenia
  4/5/02 Hyperammonemia
  6/21/02 Hemophagocytic syndromes
Grossman, Brenda 8/21/09 Transfusion medicine overview (PowerPoint)
Gu, Michael 10/5/01 PC-SPES herbal supplements for advanced prostate cancer
  2/22/02 Effects of glutamate receptor antagonists on tumor growth
  4/5/02 Cancer of unknown primary
  4/26/02 NK T-cell lymphoma
  11/1/02 Management of AML in the elderly (PowerPoint)
  2/28/03 Regional therapy of liver metastases from colorectal cancer (PowerPoint/HTML)
  5/9/03 Solitary plasmacytoma of bone (PowerPoint)
  11/21/03 Treatment of gastroenteropancreatic endocrine tumors (PowerPoint)
Hayashi, Robert 1/31/03 Thrombolytic therapy in the neonate
  4/30/04 Brown recluse spider bites (PowerPoint)
Heldermon, Coy 9/3/04 Merkel cell carcinoma (PowerPoint)
  1/28/05 Chronic lymphocytic leukemia (PowerPoint/HTML)
  6/3/05 Endocrine therapy of breast cancer (PowerPoint)
  10/14/05 Breast cancer biomarkers (PowerPoint)
  3/24/06 Bevacizumab use for metastatic breast cancer (PowerPoint)
  12/15/06 Her-2 or not (PowerPoint)
  3/2/07 Neoadjuvant chemotherapy of breast cancer (PowerPoint)
  10/19/07 Gene therapy and the mucopolysaccharidosis IIIb mouse model
  12/19/08 Splenomegaly and cytopenia: please wait for the path! (PowerPoint)
Hickman, Scot 10/25/02 Molecular indicators of prognosis in CLL
  3/12/04 Two cases: (1) Malaria; (2) Colorectal cancer with persistently elevated CEA due to medullary carcinoma of the thyroid (PowerPoint)
  3/11/05 Evans syndrome and combined variable immunodeficiency (PowerPoint)
  1/13/06 A woman with a kidney mass and a lumbar spine lesion (renal cell carcinoma) (PowerPoint)
  12/12/08 DVTs - Old and potentially new therapy modalities (PowerPoint)
  1/22/10 History of VA Hematology and Oncology (PowerPoint)
Hsieh, Jim 2/24/06 Overview of PPAR family proteins (PowerPoint)
Hugge, Christopher 3/28/03 Nijmegen breakage syndrome (PowerPoint)
  4/25/03 Methemoglobinemia (PowerPoint)
Hulbert, Monica 10/31/03 Multifocal osteosarcoma
  3/26/04 A complex hemoglobinopathy (Hgb Constant Spring & Hgb E)
Jacoby, Meagan 11/2/07 Total lymphoid irradiation for HSCT conditioning: from mice to humans (PowerPoint)
  4/11/08 Cancer epigenetics: overview of the role of methylation (PowerPoint)
  5/23/08 The use of rFVIIa in combat and civilian trauma: primum non nocere? (PowerPoint)
  10/10/08 Treatment-related MDS/AML (PowerPoint)
  3/6/09 A typical medicine patient with an atypical hematologic problem (PowerPoint)
Johnson, Bruce 4/28/06 Impact of epidermal growth factor receptor mutations on the treatment of lung cancer
Jungheim, Emily 9/19/08 Fertility preservation in 2008: options for patients facing gonadotoxic therapies (PowerPoint)
Kanter, Julie 10/27/06 Malignant mesenchymoma: a review of the literature and treatment options (PowerPoint/HTML)
  2/23/07 The clinical implications of treating patients with Li-Fraumeni syndrome (PowerPoint)
Khoury, Hanna 3/15/02 Update on treatment of CML
  1/9/04 AML and HIV (PDF)
Kommareddy, Aruna 10/11/02 Malignant pleural mesothelioma (PDF)
  12/20/02 Venous thromboembolism and cancer (PowerPoint)
  3/21/03 Gastrointestinal stromal tumors (PowerPoint)
  4/25/03 Combined modality therapy for esophageal cancer (PowerPoint)
  11/14/03 High dose estrogen therapy in metastatic breast cancer (PowerPoint)
  1/30/04 Metastatic non small cell lung cancer: options for patients with poor performance status or co-morbid conditions
  1/7/05 A phase II randomized study of intermediate and high dose estradiol in metastatic breast cancer (PowerPoint)
Kornfeld, Stuart 6/28/02 Hepcidin and the anemia of chronic disease (PowerPoint)
  10/17/03 Heat shock protein 90: molecular target for cancer therapeutics
  2/18/05 Mechanism of action of IVIG in treatment of ITP (PowerPoint)
  3/17/06 Intravascular hemolysis and pulmonary hypertension in sickle cell disease (PowerPoint)
  9/22/06 Molecular origins of chronic myeloproliferative disorders (PowerPoint)
  5/9/08 The Tn-polyagglutination/hemolytic syndrome - an explanation after 50 years (PowerPoint)
  11/14/08 Use of very low doses of single chain bivalent antibodies in the immunotherapy of cancer (PowerPoint)
  1/8/10 History of the Division of Hematology 1938-1966 (PowerPoint)
Kratzke, Robert 11/22/02 Role of p16INKa in mesothelioma and lung cancer
Kunter, Ghada 1/21/05 Congenital polycythemia (PowerPoint)
  6/3/05 Transient myeloproliferative disorder in Down syndrome (PowerPoint)
  12/14/07 CSF3R mutations confer a strong clonal hematopoietic stem cell advantage via activation of Stat5 (PowerPoint)
Kuperman, David 9/17/04 Athracycline induced cardiomyopathy: mechanisms and prevention (PowerPoint)
  2/4/05 Graft vs. host disease: pharmacologic prevention (PowerPoint)
  6/17/05 Targeted therapies in AML (PowerPoint)
  10/28/05 Autologous stem cell transplant for AML (PowerPoint)
  3/3/06 Targeted therapies for squamous cell cancer of the head and neck (PowerPoint)
  2/9/07 Induction therapy for squamous cell cancer of the head and neck (PowerPoint)
  4/27/07 Autologous stem cell transplants for solid tumors (PowerPoint)
  1/4/08 HPV and squamous cell cancer of the head and neck (PowerPoint)
Ley, Tim 3/28/08 Genomics of AML
Lim, Kian-Huat 10/9/09 Aurora kinases as anticancer targets (PowerPoint)
  12/11/09 Circulating tumor cells in cancer prognosis and diagnosis (PowerPoint)
Linette, Gerry 2/15/02 Treatment of advanced melanoma
  4/7/06 Brain tumor update (PowerPoint)
  4/6/07 Cancer immunotherapy update (PowerPoint)
  4/4/08 New agents in metastatic melanoma: sorafenib (PowerPoint)
Link, Dan 4/9/04 Shwachman-Diamond syndrome (PowerPoint)
  4/8/05 G-CSF receptor mutation in severe congenital neutropenia (Kostmann's syndrome) (PowerPoint)
  3/10/06 Endothelial progenitor cells to induce therapeutic angiogenesis (PowerPoint)
  3/2/07 Pathogenesis of severe congenital neutropenia (PowerPoint)
  9/14/07 Overview of research in the Stem Cell Biology Section
  5/1/09 Molecular pathogenesis of severe congenital neutropenia (PowerPoint)
Lockhart, Craig 9/21/07 Multidisciplinary phase I studies in oncology: the new & current standard
  5/22/09 Pharmacogenomics in cancer clinical trials (PowerPoint)
Lombardi, Donald 3/18/05 Tetraspanins in the progression of human cancers
  3/3/06 Tetraspanins in normal cellular processes and malignancy (PowerPoint/HTML)
  3/23/07 Treatment and biology of HER-2/neu gene amplified breast cancer
Lublin, Doug 7/28/06 Transfusion (PowerPoint)
Ma, Cynthia 11/5/04 Aromatase inhibitors, aromatase gene and aromatase pharmacogenomics
  10/20/06 Adjuvant chemotherapy for estrogen receptor positive breast cancer: more questions than answers (PowerPoint)
  1/18/08 An exploratory study of UCN-01 in combination with irinotecan for the treatment of advanced triple negative breast cancer (PowerPoint)
  10/17/08 Targeting Chk1 in TP53 mutated triple negative breast cancer
Majerus, Elaine 10/12/01 Familial adenomatous polyposis
  2/22/02 Hemoglobin E/beta-thalassemia
  3/22/02 Pyruvate kinase deficiency and 2,3-bisphosphoglycerate
  9/6/02 Diagnosis and treatment of multiple myeloma (PowerPoint)
  1/17/03 Von Hippel-Lindau syndrome (PowerPoint)
  2/16/07 Familial thrombocytopenias (PowerPoint)
  2/1/08 Survival on Mount Everest (PowerPoint)
  2/20/09 Eculizumab and atypical HUS (PowerPoint)
Majerus, Phil 1/9/04 Lymphoplasmacytic lymphoma (PowerPoint)
  2/4/05 Oral iron chelators (PowerPoint)
  11/17/06 The association of ITP with TTP in a young woman (PowerPoint)
  1/11/08 A case of thrombosis (PowerPoint)
  10/24/08 Iron deficiency vs anemia of chronic disease (PowerPoint)
  1/8/10 History of the Division of Hematology 1966-2009 (PowerPoint)
Martin, Mike 10/13/06 Management of a Jehovah's Witness with TTP (PowerPoint)
  12/15/06 Pemetrexed in thoracic malignancies (PowerPoint)
  3/30/07 How Andy Warhol treated myelodysplastic syndrome (PowerPoint)
  2/8/08 Induction therapy in elderly AML (PubMed)
  9/19/08 Management of the advanced phases of CML (PowerPoint)
  12/19/08 Abigail, Ezekiel and Freireich (PowerPoint)
Mathews, Vikram 10/10/03 Leukemic and stromal cell interactions: relevance to therapy of acute leukemia (PowerPoint)
  3/19/04 Role of T cell depleted HLA identical sibling stem cell transplantation for AML in CR1 (PowerPoint)
Mauro, David 5/14/04 Erbitux pharmacogenomics: genomic strategies and clinical applications towards patient selection
McDonald, Sharon 3/7/08 Malignant rhabdoid tumor of the liver (PowerPoint)
  4/11/08 Donor lymphocyte infusions in the pediatric population (PowerPoint)
McLeod, Howard 3/8/02 5-FU pharmacogenomics
  5/21/04 What will it take to move beyond anatomy-based therapy for cancer? (PowerPoint
  5/27/05 Genetic strategies to find predictors of chemotherapy effect (PowerPoint)
Michel, Loren 3/31/06 A role for the Trop-2 receptor in transformation and tumor maintenance
  10/31/08 Analysis of Trop-2 function in epithelial carcinogenesis
Morgensztern, Daniel 10/28/05 Neoadjuvant therapy for esophageal cancer (PowerPoint)
  10/13/06 Carcinoma of unknown primary (PowerPoint)
  11/30/07 Adjuvant chemotherapy for non-small cell lung cancer (PowerPoint)
  11/21/08 Update on small cell lung cancer (PowerPoint)
Mosley, James 10/6/06 Malignant peripheral nerve sheath tumor (PowerPoint)
  2/23/07 Management of mechanical complications of lung cancer (PowerPoint)
  5/25/07 Hormone-refractory prostate cancer: current trends and future directions (PowerPoint)
  2/1/08 Defining the role of cetuximab in head and neck squamous cell carcinoma (PowerPoint)
  4/18/08 Adrenocortical carcinoma (PowerPoint)
  10/17/08 Recent advances in the treatment of CLL
  6/12/09 Treatment trends for soft tissue sarcomas
Nagaraj, Gayathri 10/16/09 Glucocorticoids - a clinical conundrum (PowerPoint)
Naughton, Mike 2/25/05 Bisphosphonates in oncology (PowerPoint)
Nervi, Bruno 11/18/05 Biology of stem cell and leukemia cell mobilization (PowerPoint)
  3/17/06 Novel strategies to control GVHD (PowerPoint/HTML)
Nestor, Pat 9/14/01 Methylation of RASSF1A tumor suppressor gene
  1/11/02 COX inhibitors and prostate cancer
  3/29/02 Expression of bone-specific proteins by prostate cancer cells
  9/6/02 Prophylactic radiation therapy for bone metastases in prostate and breast cancer
  2/21/03 The role of beta3 integrin in bone metastasis (PowerPoint/HTML)
Nolta, Jan 11/7/03 The potential for stem cell-mediated tissue repair (PowerPoint)
  2/10/06 Immunodeficient mouse models to examine the effects of hypoxia on adult stem cell homing in tissue repair
Pallera, Arnel 9/21/01 Primary breast sarcoma
Papageorgio, Chris 1/11/02 Mastocytosis
Peles, Shachar 9/26/03 Cutaneous T cell lymphoma (PowerPoint)
  2/6/04 An unusual aplastic (pure red cell aplasia and thymoma) (PowerPoint)
  10/29/04 Angioimmunoblastic T-cell lymphoma (PowerPoint)
  12/16/05 Treatment of early stage diffuse large B cell lymphoma (PowerPoint)
  5/12/06 Hematopoietic stem cell transplant in CLL (PowerPoint)
Picus, Joel 5/7/04 5 alpha reductase inhibitors and prostate cancer
  10/14/05 New targets for prostate cancer
  9/4/09 Sleep deprivation
  1/29/10 History of the Division of Oncology: filling in the gaps (PowerPoint)
Pillot, Giancarlo 9/12/03 PET scanning in staging of non-small cell lung cancer (PowerPoint)
  1/30/04 Adrenal carcinoma (PowerPoint)
  12/10/04 Low grade follicular lymphomas (PowerPoint)
  4/8/05 Predicting risk in early stage non-small cell lung cancer to tailor adjuvant chemotherapy
  1/27/06 Surgery for abdominal metastases in colorectal cancer (PowerPoint)
  5/5/06 Update on locally advanced non-small cell lung cancer (PowerPoint)
Plass, Christoph 11/30/01 Aberrant DNA methylation profiles in cancer
Pomerantz, Mark 9/15/06 Hormones, genes and prostate cancer risk
Ponder, Kathy 11/1/02 Gene therapy for hemophilia (PowerPoint)
  2/13/04 A patient with hypoxemia and cyanosis (Hgb-M Saskatoon) (PowerPoint)
  2/11/05 Treatments for hemophilia A patients with inhibitors (PowerPoint)
  2/2/07 New treatments for iron overload (PowerPoint)
  6/5/09 A 57 year old Filipino man with a hemoglobin of 3.3 (PowerPoint)
Ramirez, Pablo 3/27/09 Umbilical cord blood transplantation in acute leukemias (PowerPoint)
Ramsingh, Giri 11/9/07 Regulatory T-cells and graft versus host disease (PowerPoint)
  1/18/08 p53: new twist to the old story (PowerPoint)
  4/25/08 Endogenous retroviruses: evolution and cancer (PowerPoint)
  9/5/08 Genomic instability and multiple mutations in cancer (PowerPoint)
  4/3/09 RNA based therapy (PowerPoint)
  10/9/09 Cancer: a Darwinian process (PowerPoint)
Rao, Aarati 9/26/03 Alloimmunization in sickle cell disease
  12/19/03 FAP gene and hepatoblastoma (PowerPoint)
  2/20/04 Familial Diamond-Blackfan anemia (PowerPoint)
  4/9/04 Beckwith-Wiedemann syndrome/idiopathic hemihypertrophy: clinical implications and screening (PowerPoint)
Ratner, Lee 5/23/03 Human T-cell leukemia virus and adult T-cell leukemia/lymphoma (PowerPoint/HTML)
  9/19/03 Adult T cell leukemia/lymphoma (PowerPoint/HTML)
  9/17/04 HTLV-1 and ITP (PowerPoint/HTML)
  2/22/08 Overview of research in the Molecular Oncology Section (PowerPoint)
Read, Will 9/7/01 Does SV40 cause cancer in humans?
  3/1/02 Thiazolidinediones, PPARs, and cancer
  6/7/02 Bronchioloalveolar carcinoma
  5/9/03 Tonsillar cancer
Rigden, Caron 9/24/04 Primary mediastinal B-cell lymphoma (PowerPoint)
  2/11/05 Glioblastoma multiforme (PowerPoint)
  2/10/06 Treatment of advanced and metastatic gastric cancer (PowerPoint)
  5/4/07 Her2 positive breast cancer: beyond trastuzumab (PowerPoint)
Rodriguez, Luis 1/2/01 Pulmonary artery sarcoma masquerading as pulmonary embolism
  10/5/01 Metallic endolumenal stents for colorectal cancer
  2/15/02 Chemotherapy for androgen-independent prostate cancer
  4/19/02 Malignant thymoma
  10/18/02 Monoclonal antibodies targeting epidermal growth factor receptor (PowerPoint/HTML)
  5/2/03 Neoadjuvant therapy for rectal cancers (PowerPoint)
  6/13/03 Oncology trivia (with pastries) (PowerPoint)
Rokkam, Aruna 10/30/09 Green tea and cancer
  11/20/09 Radioembolization of hepatic metastases from colorectal cancer (PowerPoint)
  12/11/09 Merkel cell carcinoma (PowerPoint)
Rosol, Thomas 2/27/04 Parathyroid hormone-related protein: role in normal biology, cancer and bone metastasis (PDF)
Sadler, Evan 10/11/02 ADAMTS13 and thrombotic thrombocytopenic purpura
  10/10/03 Potential molecular mechanism for Trousseau syndrome (PowerPoint)
  3/26/04 Local experience in TTP (PowerPoint)
  10/1/04 Update on ADAMTS13 (PowerPoint)
  4/14/06 Rituximab for autoimmune diseases (PowerPoint)
  8/11/06 Von Willebrand disease and TTP (PowerPoint)
  4/13/07 Stroke in a nineteen year old girl with sickle cell disease (PowerPoint)
  9/28/07 Overview of research in the Hematology Division
  9/26/08 Tick bites, fever, pancytopenia (PowerPoint)
Sands, Mark 1/7/05 Hematopoietic-directed gene therapy for lysosomal storage diseases (PowerPoint)
Schroeder, Mark 10/6/06 Mysteries of the mantle zone: good is bad and bad is good except in mantle cell (PowerPoint)
  2/16/07 Steroid refractory acute GVHD (PowerPoint)
  5/18/07 Cancer stem cells: a review and implications for novel therapeutic approaches (PowerPoint)
  9/14/07 Advanced hepatocellular carcinoma after ASCO 2007 (PowerPoint)
  5/2/08 Chronic GVHD: in search of a model to understand its pathobiology (PowerPoint)
  9/5/08 Donor lymphocyte infusions for the treatment of hematologic malignancies (PowerPoint)
  4/24/09 Hematopoietic stem cell transplantation for MDS: Are we putting the cart before the horse (PowerPoint)
Schuettpelz, Laura 2/13/09 Hemophagocytic lymphohistiocytosis (PowerPoint)
Sekhar, Jeevan 2/27/09 Adult T cell lymphoma/leukemia (PowerPoint)
  3/20/09 I cured my own GVHD (PowerPoint)
  5/1/09 Pharmacologic thrombopoiesis: past, present, and future (PowerPoint)
  9/11/09 Eltrombopag therapy to increase platelet aphersis yields in healthy donors
Shad, Manish 12/17/04 An update on gastric cancer
Sharifi, Nima 1/5/07 Prostate cancer: from TGF-beta resistance to androgen independence
Shenoy, Shalini 2/28/03 Fas-mediated apoptosis in pediatric autoimmune cytopenias (PowerPoint)
Smukler, Avram 11/16/01 Treatment of aplastic anemia
  12/28/01 Hepatoma associated with AIDS
  3/29/02 Arsenic trioxide for relapsed acute promyelocytic leukemia
  6/14/02 Autologous stem cell transplantation for Hodgkin's disease
  9/20/02 Pegylated filgrastim (G-CSF)
  1/3/03 Management of bone metastases
  12/19/03 Treatment for recurrent multiple myeloma
Sorscher, Steven 10/22/04 CHEK 2 and human tumors
  5/5/06 How footpad tumors in cottontail rabbits led to HPV vaccines (PowerPoint)
  4/27/07 Rationale for cancer gene therapy: si quaeris peninsulam amoenam circumpice (PowerPoint)
  5/23/08 Tumor-to-tumor metastases (PowerPoint)
  5/8/09 Mitochondrial DNA and cancer (PowerPoint)
Stockerl-Goldstein, Keith 10/3/08 Creating a stem cell donor (PowerPoint)
Subramanian, Janakiraman 10/12/07 Lung cancer in never smokers (PowerPoint)
  1/25/08 Thrombotic microangiopathy after stem cell transplant (PowerPoint)
  6/6/08 Hemophagocytic syndromes (PowerPoint)
  1/23/09 Small cell, big problem! Are stem cells the root cause? (PowerPoint)
  10/2/09 EML4-ALK fusion gene in NSCLC (PowerPoint)
Suresh, Rama 11/15/02 Breast ductal lavage (PowerPoint)
  2/7/03 Pegylated liposomal doxorubicin (Doxil) in metastatic breast cancer (PowerPoint)
  4/4/03 Trastuzumab in metastatic breast cancer (PowerPoint)
  11/7/03 Adjuvant hormonal therapy for breast cancer...beyond tamoxifen (PowerPoint)
  2/20/04 Relapsed Hodgkin's disease (PowerPoint)
  5/19/06 Fertility preservation in cancer patients: ASCO recommendations (PowerPoint)
  5/11/07 Breast MRI (PowerPoint)
  5/2/08 KRAS mutation and the efficacy of EGFR monoclonal antibodies in metastatic colorectal cancer (PowerPoint)
  4/17/09 Zoledronic acid in early stage breast cancer (PowerPoint)
Tan, Ben 4/12/02 Adjuvant therapy of pancreatic cancer
  2/6/04 Colorectal cancer: what's new? (PowerPoint/HTML)
  10/29/04 Adjuvant treatment for colon cancer (PowerPoint)
  3/30/07 Treatment of liver-only metastatic colorectal cancer (PowerPoint)
Tollefsen, Doug 6/21/02 Alpha-hemoglobin stabilizing factor (PowerPoint)
  6/11/04 The role of hepcidin in anemia of chronic disease (PowerPoint)
  9/23/05 Does low-molecular-weight heparin improve survival of cancer patients? (PowerPoint)
  8/25/06 Anticoagulants and HIT (PowerPoint)
  3/9/07 Drug-induced thrombocytopenia (PowerPoint)
  2/22/08 Thrombopoietic agents for treatment of ITP (PowerPoint)
  8/15/08 Anticoagulants and HIT (PowerPoint)
  8/14/09 Anticoagulants and HIT (PowerPoint)
Threadgill, David 1/26/07 EGFR-inhibition therapies are dependent upon genetic and environmental context
Tomasson, Michael 6/14/02 What is the role of myc in myeloid leukemogenesis?
  1/10/03 Genomics of acute myelogenous leukemia (PowerPoint/HTML)
  11/14/03 Development of an animal model of t(4;14) multiple myeloma (PowerPoint)
  4/15/05 Apoptosis and transformation in a model of Myc-induced AML (PowerPoint/HTML)
  11/16/07 Chromosome 13 deletions in multiple myeloma
Tran, David 2/29/08 Tumor dormancy (PowerPoint)
  4/4/08 Targeting telomerase (PowerPoint)
  5/9/08 Alcohol-mediated carcinogenesis (PowerPoint)
  1/9/09 Glioblastoma multiforme (PowerPoint)
  4/17/09 Can iron deficiency cause thrombocytopenia? (PowerPoint)
Truica, Cristina 4/2/04 EGFR modulation in breast cancer
Uy, Geoff 9/19/03 Primary CNS lymphoma (PowerPoint)
  1/16/04 Update of new anticoagulants (PowerPoint)
  4/30/04 CML and resistance to Gleevec (PowerPoint)
  4/22/05 Pulmonary alveolar proteinosis (PowerPoint)
  1/20/06 Leukemia stem cells in AML (PowerPoint)
Van Tine, Brian 11/16/07 TMPRSS2-ERG or ETV1 fusions in prostate cancer (PowerPoint)
  6/13/08 SV40 and mesothelioma (PowerPoint)
  9/12/08 Chemotherapy during pregnancy (PowerPoint)
  2/6/09 New pager system orientation (PowerPoint)
Vedantham, Suresh 12/12/08 Endovascular thrombolytic therapy for acute DVT (PowerPoint)
Verkruyse, Linda 10/4/02 Hypereosinophilic syndrome
  12/20/02 Rhabdomyosarcoma
  3/14/03 Glioblastoma multiforme (PowerPoint)
  10/3/03 Angiosarcoma (PowerPoint)
  6/11/04 Chemotherapy in hormone refractory prostate cancer (PowerPoint)
  12/10/04 CMV infection: monitoring and treatment in bone marrow and stem cell transplantation (PowerPoint)
  4/29/05 Mantle cell lymphoma: current treatment strategies (PowerPoint)
Vij, Ravi 5/31/02 Chromosomal translocations in multiple myeloma
  9/5/03 Non-myeloablative transplantation (PowerPoint)
  10/8/04 Hematopoietic stem cells for cardiac ischemia (PowerPoint)
  10/19/07 Recent trends in allogeneic hematopoietic stem cell transplantation: CIBMTR data (PowerPoint)
  5/15/09 Hypomethylation: turning on silenced genes and silencing the critics? (PowerPoint)
Wagner-Johnston, Nina 10/26/07 New approaches to monitoring lymphoma
Walgren, Richard 2/18/05 Treatment of refractory idiopathic thrombocytopenic purpura (PowerPoint)
  10/7/05 Thrombotic microangiopathy and malignancy (PowerPoint)
  1/20/06 Treatment of MDS with azacitidine (PowerPoint)
  3/31/06 Credentialing of plantinum pathway genes
  11/10/06 Epigenetic changes in MDS (PowerPoint)
  4/6/07 Pharmacogenomic studies of human treatment-related MDS and AML (PowerPoint)
  3/14/08 mTOR inhibition in sarcoma (PowerPoint)
Walter, Matt 9/28/01 CLL: familial vs. environmental factors
  11/16/01 Essential thrombocythemia
  4/4/03 Imatinib in hypereosinophilic syndrome (PowerPoint)
  10/21/05 A patient with AML and shortness of breath (PowerPoint)
  11/10/06 Detection of deletions and amplifications in primary AML genomes
  3/27/09 DNA copy number alterations in acute leukemia (PowerPoint)
Wang-Gillam, Andrea 6/13/08 VEGFR1 and PIGF: novel targets in angiogenesis (PowerPoint)
  6/12/09 Novel targets in pancreatic cancer (PowerPoint)
Waqar, Saiama 10/3/08 Diagnostic strategies for carcinoma of unknown primary (PowerPoint)
  1/16/09 Primary intraocular lymphoma (PowerPoint)
  3/13/09 Cutaneous toxicities of cancer therapy (PowerPoint)
  5/22/09 Evolving treatment paradigms for stage III NSCLC (PowerPoint)
  10/23/09 A Phase I/II trial of temsirolimus and pemetrexed in recurrent/refractory non-small cell lung cancer (NSCLC)
Wartman, Lukas 11/2/07 Update on the use of epoetin and darbepoetin (PowerPoint)
  12/14/07 Atypical HUS (PowerPoint)
  9/18/09 Atypical hemolytic uremic syndrome: an update and story of a clinical trial
Weilbaecher, Kathy 2/25/05 Mechanisms of bone metastases
  5/26/06 Mechanisms of bone metastasis (PowerPoint/HTML)
  4/20/07 G-CSF enhances bone tumor growth in mice in an osteoclast-dependent manner (PowerPoint)
Welch, John 10/20/06 APL and ATRA: sure it works, but how? (PowerPoint)
  1/12/07 CML: goal oriented therapy (PowerPoint)
  5/11/07 Post-chemotherapy nausea (PowerPoint)
  11/30/07 How much blood do you need? (PowerPoint)
  3/7/08 Splenic lesions in transformed follicular lymphoma (PowerPoint)
  3/13/09 ITP and thrombopoiesis (PowerPoint)
  5/8/09 Waldenström's: treatment and transformation (PowerPoint)
Westervelt, Peter 9/28/07 Overview of research in the BMT Section
Wildes, Tanya 9/23/05 Treatment of Langerhans cell histiocytosis (PowerPoint)
  1/6/06 Chemotherapy and fertility (PowerPoint)
  4/21/06 Acute leukemia and intracerebral hemorrhage (PowerPoint)
  2/9/07 Targeted therapy in relapsed Hodgkin's disease (PowerPoint)
  4/13/07 Physical activity and cancer risk (PowerPoint)
  9/7/07 Fellows protocol discussion (PowerPoint)
  2/15/08 Comorbidities and geriatric assessments in older adults with cancer (PowerPoint)
Williams, Kerry 9/22/06 Medullary renal carcinoma - the seventh sickle cell nephropathy (PowerPoint)
  1/12/07 Irinotecan: can we predict toxicity? (PowerPoint)
  4/20/07 Burkitt's lymphoma mimicking a gynecological malignancy (PowerPoint)
  1/11/08 BSA - paradigm or prehistoric (PowerPoint)
  4/25/08 Helicobacter pylori - the good, the bad and the ugly (PowerPoint)
  9/12/08 Sickle cell hepatopathy and the role of liver transplantation (PowerPoint)
  1/9/09 EWS-WT1 gene fusion: the case of a small round tumor (PowerPoint)